Email [email protected] Dissertation Investigating Transcriptional Dyregulation in Disease Through Genetic Engineering and Therapeutic Inhibition Mentor Scott W. Lowe, PhD Start Year 2019 End Year 2026 Education BS, The College of New Jersey; Cancer Biology Fellowships Ruth L. Kirschstein Predoctoral Individual National Research Service Fellowship, NIH National Cancer Institute (2022-2025) Publications Li X, Huang CH, Sánchez-Rivera FJ, Kennedy MC, Tschaharganeh DF, Morris JP 4th, Montinaro A, O’Rourke KP, Banito A, Wilkinson JE, Chen CC, Ho YJ, Dow LE, Tian S, Luan W, de Stanchina E, Zhang T, Gray NS, Walczak H, Lowe SW.(2022) A preclinical for assessing antitumor effects and systemic toxicities of cancer drug targets. Proc Natl Acd Sci USA.Kennedy MC, Lowe SW. (2022) Mutant p53: it’s not all one and the same. (2022) Cell Death Differ EpubSánchez-Rivera FJ, Diaz BJ, Kastenhuber ER, Schmidt H, Katti A, Kennedy M, Tem V, Ho YJ, Leibold J, Paffenholz SV, Barriga FM, Chu K, Goswami S, Wuest AN, Simon JM, Tsanov KM, Chakravarty D, Zhang H, Leslie CS, Lowe SW, Dow LE; Base editing sensor libraries for high- throughput engineering and functional analysis of cancer-associated single nucleotide variants.; Nature biotechnology; 2022; 40(6):862-873; PMC9232935; View a full listing of Margaret Kennedy’s journal articles.
